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Abstract
Objective—Obesity increases cardiovascular disease risk and adversely affects vascular structure
and function. Few studies have evaluated the vascular effects of non-surgical weight reduction in
the severely obese. We hypothesized that weight loss and improvements in cardiometabolic
factors would reduce common carotid artery intima-media thickness (CIMT) and inter-adventitial
diameter (AD) in severely obese adults.
Methods—We performed carotid ultrasound and measured cardiometabolic factors in 90
severely obese participants (body mass index (BMI)≥35 kg/m2, age 30–55) at baseline and 6
months in a randomized clinical trial of dietary intervention with (n=45) or without (n=45)
physical activity.
Results—The achieved weight loss (mean=8%) did not differ significantly by intervention group
(P=0.10) and resulted in a 0.07 mm mean decrease in AD (P=0.001). AD change was positively
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correlated with changes in BMI, waist circumference, abdominal visceral and subcutaneous fat,
and body fat mass, and AD decreased more in men (P<0.05 for all). After multivariable
adjustment, changes in BMI (P=0.03) and abdominal subcutaneous fat (P=0.04) were significant
determinants of AD change. Although CIMT did not decrease significantly overall (−0.008 mm,
P=0.16), individuals who lost at least 5% of their body weight experienced a significant mean
reduction in CIMT of 0.02 mm (P=0.002). CIMT change was positively correlated with changes in
BMI, waist circumference, fat-free mass, leptin, and insulin (P<0.05 for all). After multivariable
adjustment, insulin reduction remained a significant determinant of CIMT decrease (P=0.03).
Conclusion—A6 month intensive behavioral intervention can significantly reverse metabolic
and vascular abnormalities in severely obese adults.
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INTRODUCTION
Obesity adversely affects vascular structure and function by increasing total blood volume
and cardiac output, which can increase arterial wall stress, vascular smooth muscle cell
proliferation, and vascular wall thickness and diameter . Weight loss reverses some of these
adverse vascular changes and improves cardiovascular disease risk factors such as high
blood pressure, dyslipidemia, insulin resistance, and elevated circulating levels of C-reactive
proteinand adipokines . The fastest growing segment of the obese population is the severely
obese, those with body mass index (BMI) ≥ 40 kg/m2. In this population, weight loss may be
achieved most efficiently through bariatric surgery due to the difficulties of achieving long-
term success with lifestyle modifications . However, since only about 1% of the severely
obese population receives bariatric surgery annually, non-surgical interventions warrant
further consideration . Though there is skepticism regarding the ability of severely obese
persons to achieve and sustain substantial non-surgical weight loss, there exists some
evidence that intensive medical interventions can be effective .
Carotid intima-media thickness (CIMT) is a validated surrogate measure of subclinical
atherosclerosis that is predictive of vascular events . Improvements in cardiovascular risk
factors occurring with lifestyle modification are associated with favorable changes in
CIMT . Carotid inter-adventitial diameter (AD) is another measure of arterial remodeling
and predictsvascular events independent of CIMT.In large arteries, obesity is accompanied
by diameterexpansion resulting from elevated circulating blood volume and pressure.This
occurs concurrently with intima-media thickening, a process more reflective of
atherosclerotic progression . This structural adaptive response to inflammatory, metabolic,
and hemodynamic factors aims to maintain a balance between shear and tensile stresses in
the vessel wall .
In the severely obese, bariatric surgery improves cardiovascular risk factors and results in
the regression of CIMT , but questions remain as to whether clinically meaningful
improvements in vascular structure can be achieved with lifestyle modification.Investigating
whether intensive lifestyle interventions can effectively reduce cardiovascular disease risk in
the severely obese will inform evidence-based guidelines allowing clinicians to provide
more appropriate treatment recommendations to this population. We studied severely obese
participants in a randomized clinical trial that assessed the impact of a dietary intervention
with or without physical activity on weight loss, body composition, cardiometabolic factors,
and common carotid artery structure . We hypothesized that weight loss and improvements
in cardiometabolic factors, regardless of intervention assignment, would be associated with
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reductions in CIMT and AD over the course of the 6 month intervention. Additionally, we
hypothesized that participants who received the physical activity intervention would achieve
greater weight loss and greater reductions in CIMT and AD than participants who received
only the dietary intervention.
METHODS
Subject Recruitment / Randomization
Recruitment and randomization methodshave been previously described. Briefly,
participants were randomized into two study groups, with blocking according to sex, level of
obesity (class II and III), and race/ethnicity (African American and white). Evaluators of all
measures were blinded to group assignment. The study was reviewed and approved by the
human ethics committees of the University of Pittsburgh with all participants providing
written informed consent prior to enrollment.
Inclusion/Exclusion Criteria
Participants between the ages of 30 and 55 years were eligible if they were severely obese,
defined in this study as a BMI between 35 and 39.9 kg/m2 for class II obesity and ≥40 kg/m2
for class III obesity. Participants had to be able to walk without assistance, commit to the
schedule of intervention and assessment visits, and obtain medical clearance for
intervention. Candidates were excluded if they had a history of cancer within the past 5
years, had a history of or were receiving current treatment for coronary artery disease, had
enrolled within the past year in a formal weight reduction program, reported losing more
than 5% of their current body weight in the previous 6 months, had a history of bariatric
surgery, uncontrolled hypertension, diabetes, or were pregnant during the previous 6
months.
Treatment Groups
All participants were randomized to a 12-month lifestyle intervention . One group was
randomized to diet and physical activity for 12 months, while the other group had the
identical dietary intervention but physical activity was delayed for 6 months. The primary
goal of the trial was to examine the effect of an intensivelifestyle intervention on weight
lossin severely obese adults and specifically to assess whether adoption of a physical activity
program in addition to a dietary intervention would promote additionalweightlosscompared
to a dietary intervention alone.Vascular measurements, which were not the primary
measures of interest in this trial, were performed at only the baseline and 6 month
visits.Thus, intervention group comparisons for the present study were diet plus physical
activity (“Diet+PA”) versus diet alone (“Diet”). The behavioral lifestyle intervention
program was delivered with a combination of group, individual, and telephone contacts.
During months 1 through 6, participants received 3 group meetings and 1 individual contact
per month. All participants were prescribed a diet shown to produce a sustained 8-10%
weight loss within 12 months . Calculated energy intake was based on initial body weight
and reduced to a target of between1200 and 2100 kcal/day. Targeted macronutrient
composition was 20% to 30% fat, 50% to 55% carbohydrate, and 20% to 25% protein. To
facilitate dietary compliance and improve weight loss , liquid and prepackaged meal
replacements were provided at no cost for all but 1 meal per day during months 1 through 3
and for only 1 meal per day during months 4 through 6 of the intervention. Adherence to the
dietary intervention was monitored by having participants record the time of meals as well
as the type and caloric value of food consumed. For the Diet+PA intervention group,
moderate intensity physical activity, similar to brisk walking, was recommended and
progressed by 5-10 min/day in 4 week intervals to eventually reach 60 minutes, 5 days per
week. To maximize adoption and maintenance of physical activity, participants were
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permitted to accumulate multiple 10-minute bouts of physical activity per day, were
provided with a pedometer and step goals of more than 10,000 steps per day, and were
instructed to self-monitor their physical activity in a weekly diary. To promote adherence,
participants were provided with low-cost supplies related to the intervention (e.g.
pedometer, exercise videos) and were eligible to periodically receive small financial
incentives for adherence to the behavioral goals of the intervention.
Study Measures
Anthropometric / Physical—Body weight, height, and waist circumference were
measured using standard protocols . Computed tomography (CT) scans (GE Light Speed CT
scanner, GE Healthcare, Milwaukee, WI) were performed to quantify abdominal adipose
tissue as previously described . Body fat and fat-free mass were determined either by dual-
energy x-ray absorptiometry (DXA) (Lunar iDXA, GE Healthcare, Piscataway, NJ) or by air
displacement plethysmography in 24 participants exceeding the weight capacity of the DXA
scanner (136kg) (BOD POD, Life Measurement, Inc., Concord, CA). Blood pressure was
measured with an automated system (Dinamap, GE Healthcare, Freiburg, Germany) after
participants had sat quietly for 5 minutes. The average of the last 2 of 3 readings taken one
minute apart was used.
Serum measures
Fasting blood samples were collected for the measurement of glucose, insulin, C-reactive
protein, adiponectin, leptin, and lipids. Insulin resistance was calculated using the
homeostatic model of insulin resistance assessment method . Adiponectin levels were
assessed using xMAPTM bead-based technology (Luminex Corp., Austin, TX). Enzyme-
linked immunoassays were used to determine insulin (Millipore, Billerica, MA), leptin
(R&D Systems, Minneapolis, MN) and C-reactive protein (Helica Systems, Inc., Fullerton,
CA). Total cholesterol, high density lipoprotein cholesterol, low density lipoprotein
cholesterol, triglycerides, and glucose were determined using standard laboratory procedures
as previously described .
Physical Activity
Objective measures of physical activity were quantified using multisensor physical activity
monitors (Sensewear Pro3; BodyMedia, Pittsburgh, PA) worn between 7 and 11 consecutive
days (mean(SD), 7.2(1.8) days; 23.1(0.6) hours/day) at baseline and 6 months.
Carotid Ultrasound
Primarily because of scheduling conflicts, only 90 of the 130 trial participants received a
carotid ultrasound exam at both baseline and 6 months. CIMT was assessed by B-mode
ultrasonography of the left and right common carotid arteries (CCA) with a Philips (Agilent)
Imagepoint HX Ultrasound B-Mode duplex scanner (Philips, Andover, MA). Certified
vascular sonographers from the University of Pittsburgh Ultrasound Research Laboratory
performed the scans. Digitized images for reading were obtained from the left and right
distal CCA, 1 cm proximal to the carotid bulb. CIMT measures were generated by
electronically tracing the lumen-intima and media-adventitia interfaces across a 1 cm
segment of both the near and far wall CCA. CCA inter-adventitial diameters were measured
directly as the distance from the adventitial-medial interface on the near wall to the medial-
adventitial interface on the far wall at end-diastole across the same CCA segments. For
analyses, the mean of the average CIMT and AD values were used. The reading software
used was the AMS system developed by Dr. Thomas Gustavsson. Replicate scanning (n=14)
yielded an intraclass correlation (ICC) of 0.82 for CIMT and 0.83 for AD and replicate
readings (n=20) yielded ICCs of 0.98 for CIMT and 0.95 for AD.
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Descriptive statistics were calculated for demographic variables, cardiometabolic factors,
CIMT, and AD. Differences in baseline characteristics between arms were assessed using t-
tests or Mann-Whitney U tests for continuous variables and the chi-square test or Fisher’s
exact test for categorical variables. The same analysis was performed to evaluate differences
between trial participants with both baseline and 6 month carotid ultrasound scans
(n=90)and trial participants missing carotid data at either time point (n=40) or at 6 months
only (n=19). Six month changes overall and within intervention arms were assessed using
paired t-test or related samples Wilcoxon signed ranks test. Differences between arms were
assessed using two-way analysis of variance (ANOVA) with adjustment for the sex
difference between arms and log transformation of C-reactive protein and triglycerides.
Pearson correlations were used to assess the associations between changes in CIMT or AD
and changes in cardiometabolic factors.Mean changes in AD and CIMT were compared
betweena priori subgroups based on baseline BMI or percent weightlossusing two-way
ANOVA adjusting for intervention arm.The parent trial was not designed to have sufficient
power to detect between-arm differences in vascular measures; 45 subjects in each
intervention arm would provide a power of 8% to detect a between-arm difference of 0.005
mm in change in CIMT assuming a common standard deviation of 0.05 mm, and a power of
22% to detect a between-arm difference of 0.05 mm in change in AD assuming a common
standard deviation of 0.2 at p <0.05. However, this study had more than 80% power to
detect a Pearson correlation coefficient of 0.30 between BMI change and CIMT or AD
change at p < 0.05.
Separate linear regression models were used to identify variablesassociated with 6 month
changes in CIMT and AD. All cardiometabolic risk factors of interest were considered for
inclusion in the models. The first multivariable model included intervention arm and when
significant at p<0.10 also included age, sex, race (black/non-black), and change in BMI. For
the fully-adjusted multivariable models, additional variables with P<0.20 in simple
correlations with CIMT or AD were considered. Each variable was added sequentially to the
first multivariable model and variables with P<0.10 were kept in the final model. To
evaluate the sensitivity of our results to the assumption of the missing data being missing
completely at random, we evaluated linear mixed effects models for AD and CIMT. For the
same covariates included in the multivariable linear regression models, baseline values and
changes from baseline (for time-varying covariates) or the interaction of time with the
baseline value (for time-invariant covariates) were included in the mixed models. All
analyses were performed using SAS (version 9.2, SAS Institute, Cary, North Carolina). The
level of statistical significance was set at a 2-sided P-value of 0.05.
RESULTS
CIMT and AD were measured at both time points in 90 participants. Key demographic and
clinical characteristics are presented in Table 1. There were no significant differences in
baseline characteristics between intervention groups except that there were more men in the
Diet+PA arm. Time spent in vigorous activity also showed a marginally significant
difference between groups (Table 1).
Body weight, total body fat, waist circumference, and abdominal adipose content decreased
in both intervention groups over the course of the study (Table 2). In the overall study
sample, significant improvements were also seen in fasting glucose, insulin, homeostatic
model assessment of insulin resistance, leptin, adiponectin, C-reactive protein, and AD. The
Diet+PA arm showed a greater reduction in waist circumference than the Diet arm (P=0.04),
but other changes were not statistically significantly different between arms (Table 2). The
increase in number of steps per day was marginally greater in the Diet+PA arm (Table 2); 12
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out of 41 (29%) subjects in the Diet+PA arm averaged at least 10,000 steps/day at 6 months.
Interestingly however, 8 out of 41 (20%) of subjects in the Diet arm averaged at least 10,000
steps/day at 6 months, so some individuals in the Diet arm clearly chose to initiate PA
before they were advised to do so. AD decreased more in men than women, and change in
AD was positively correlated with age and changes in all measures of adiposity (Table 3).
Change in CIMT was positively correlated with changes in BMI, weight, waist
circumference, fat-free mass, leptin, and insulin. Neither CIMT change nor AD change was
associated with changes in blood pressure or lipids, either in the total sample or in those not
on medications affecting these respective measures.
Further analysis by BMI subgroup revealed that the most severely obese participants
(baseline BMI ≥ 45 kg/m2) experienced the numerically greatest decreases in CIMT and
AD, but these decreases were not statistically significantly different from those of less obese
individuals (p>0.15 for both).Individuals who lost ≥5% of their body weight experienced a
significantreduction in mean CIMT (−0.02 mm, P=0.002) whereas individuals who lost <5%
of their baseline body weight experienced a small increase in CIMT(0.025 mm, P=0.02)(see
Figure 1 in online supplement). Those subjects who achieved ≥5% weight loss were more
likely to be in the Diet+PA arm (56% vs. 44%, P=0.06).Importantly, the increase in CIMT
in the group that achieved<5% weight losswas influenced by one outlier, an individual with
an increase in CIMT of 0.12 mm and a decrease in AD of 0.44 mm. This individual may
have experienced a decrease in CIMT after 6 months as the carotid artery had additional
time to adapt to the large decrease in diameter. When this subject was removed from the
analysis, the increase in CIMT in this subgroup was no longer statistically significant
(p=0.07).
In the first multiple linear regression model, change in BMI was positively associated with
change in CIMT after adjusting for intervention arm (Table 4). In the fully adjusted model,
only change in fasting insulin was associated with 6 month change in CIMT (Table 4).
Change in the homeostatic model assessment of insulin resistance showed a nearly identical
association (P=0.03) with change in CIMT when included in the model in place of insulin.
Different factors were found to explain the 6 month changes in AD and CIMT. In the first
multivariable regression model for change in AD, adjusting for intervention arm, age,
andsex, change in BMI was a highly significant determinant of change in AD (Table 5). In
the fully adjusted model, male sex and greater reductions in BMI and abdominal
subcutaneous fat were associated with greater reductions in AD (Table 5). No significant
interactions were detected in the fully adjusted models for either CIMT or AD.
As a sensitivity analysis, in linear mixed models for AD and CIMT, 19 subjects who had
baseline but no 6 month carotid data were added to the analysis. Of all baseline measures,
only age differed between these subjects (42.9 years, SD 6.1)and the 90 subjects with
complete carotid data (47.1 years, SD 6.4) (P=0.01). Results from the linear mixed models
were similar to those from the linear regression models, with change in insulinshowing an
association with CIMT change (P=0.05) and changes in BMI (P=0.02) and abdominal
subcutaneous fat (P=0.02) showing associations with AD change.
DISCUSSION
This study clearly shows that significant improvements in common carotid artery structure
occur with an intensive lifestyle intervention in severely obese adults. The physical activity
intervention promoted a greater reduction in waist circumference but did not significantly
add to the reductions in CIMT or AD, perhaps because of the smaller than desired increase
in activity in the Diet+PA arm. The approximately 8% weight loss overall resulted in a mean
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decrease in common carotid artery AD of 0.07 mm. Though there was not a significant
reduction in mean CIMT in the total sample, individuals who achieved at least 5% weight
loss experienced a significant reduction in CIMT. Our results demonstrate that an intensive
dietary intervention can significantly reverse some of the key adverse cardiometabolic and
vascular structural changes brought about by excess weight in severely obese adults.
However, the small average increase of 50 minutes in moderate to vigorous activity per
week in the Diet+PA arm in this study was insufficient to add significantly to vascular
changes over a 6 month time period.Importantly, data from a meta-analysis of 8 large
prospective studies suggest that the mean CIMT reduction of 0.02 mm in study subjects who
achieved at least 5% weight loss can be expected to reduce incident myocardial infarction
and stroke rates by 3% and 4% respectively in the long term. In addition, data from one
large prospective study suggest that the overall mean AD reduction of 0.07 mm in this study
can be expected to reduce incident coronary heart disease rates by 2% in men and 6% in
women over the next 10 years. Thus, the improvements in common carotid artery geometry
in this study may wellyieldvery meaningful long-term clinical benefits for these severely
obese individuals.
In the severely obese, bariatric surgery generates marked improvements in structural and
functional measures of atherosclerosis and arteriosclerosis . This invasive treatment option,
however, can have numerous complications and cannot be recommended to all severely
obese individuals .This is the first sizable study to report improvements in vascular structure
with an intensive lifestyle intervention in severely obese adults, with decreases in carotid
diameter being significant in the overall sample and decreases in CIMT being significant in
those who achieved at least 5% weight loss. These findings are similar to improvements in
vascular structure and function seen with 5-10% weight loss in overweight, class I, and class
II obese adults .These improvements are substantially smaller than those seen in a small
study (n=14) of severely obese adults who experienced an average of 40% weight lossas a
result of a highly intense exercise intervention (mean 3.3 hours of exercise per day)
accompanied by moderate caloric restriction over 7 months.However, such an intense
exercise intervention would be prohibitively expensive and time consuming to undertake on
a large scale. Despite the reality that conventional therapy for severe obesity is often
ineffective, intensive but widely manageable lifestyle interventions have been shown to be
effective both in the present trial and a recent randomized trial comparing an intensive
medical weight loss program in a primary care setting to usual care . The challenging key to
the effectiveness of such interventions, however, is consistent and frequent contact with
participants .
CIMT has been shown to regress or progress more slowly as cardiovascular risk factors
improve with lifestyle modification . In this study, change in CIMT was correlated with
changes in leptin, insulin, and several measures of body size. Because CIMT serves as a
measure of both early atherosclerosis and vascular adaptation to changes in hemodynamics ,
increased CIMT could represent not only early atherosclerosis but also an adaptive response
to the elevated cardiac output and blood flow that support increased metabolic needs in
obese individuals . With the accumulation of excess weight, these hemodynamic alterations,
along with concurrent hormonal and neural feedback, can lead to adverse arterial structural
changes including increased diameter and intima-media thickening . It is interesting to note
that changes in CIMT and AD showed different associations with cardiovascular and
metabolic risk factors in this study, a finding that agrees with cross-sectional studies and
suggests that distinct adaptive processes are represented by CIMT and AD .
Obese individuals have increased fat mass and fat-free mass, which together promote the
aforementioned hemodynamic alterations. Fat-free mass is a strong independent correlate of
left ventricular mass, CIMT, and CCA lumen diameter in cross-sectional studies . Excess
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adipose tissue alters circulating adipocytokine levels, such as leptin, which controls food
intake and energy expenditure and increases with increasing body fat. Hyperleptinemia has
been associated with greater oxidative stress and insulin resistance, both of whichpromote
atherosclerosis. In this study however, the association between change in leptin and change
in CIMT was explained by BMI change.
Insulin resistance and compensatory hyperinsulinemia can advance atherosclerosis by
promoting interactions between circulating monocytes and the vascular endothelium and by
enabling vascular smooth muscle cell migration and proliferation . Similar to this study, a
recent study in obese adolescents found that a decrease in homeostatic model assessment of
insulin resistance was independently associated with a reduction in CIMT during weight
loss. Perhaps in severely obese individuals, the reduction in insulin resistance accompanying
weight loss is key to the regression of early atherosclerosis and vascular maladaptation.
Interestingly, individuals losing < 5% of their baseline body weight experienced an increase
in CIMT. This could have been partly caused by a nonsignificant increase infasting insulin
in this subgroup (1.2 μU/mL, SD 1.7), which was significantly different (P=0.0001) from
the decrease in insulin (−6.6 μU/mL, SD 1.0) in those achieving at least 5% weight loss.
However, as noted, when one influential subject showing a large increase in CIMT was
removed from the analysis, the increase in CIMT in those subjects who achieved< 5%
weight loss was no longer statistically significant.
Elevated common carotid artery diameter is another structural marker of cardiovascular
disease risk that is associated with numerous cardiovascular risk factors and has been shown
to predict events .In this study, change in AD was positively correlated with changes in all
measures of body size except fat-free mass, and change in abdominal subcutaneous fat was
an independent correlate of change in AD. As with CIMT, this reflects the influence of
excess body mass on hemodynamic changes leading to vascular adaptation. The distribution
of adipose tissue is an important determinant of obesity-associated metabolic and
cardiovascular complications. Abdominal visceral fat has been found to be a strong
determinant of metabolic dysfunction and of structural and functional vascular alterations in
a general population of older adults , class I and II obese adults , and severely obese adults .
Although abdominal subcutaneous fat influences insulin resistance , it typically shows
weaker associations with metabolic and vascular dysfunction than visceral fat both in the
general population and in obese individuals. In severely obese individuals, however, total
abdominal fat may be a more important determinant of cardiovascular risk than any
abdominal fat compartment . The majority of body fat in obese adults is subcutaneous, thus
abdominal subcutaneous fat is a stronger correlate of total abdominal fat and perhaps also of
vascular structural alterations in the severely obese.
A major strength of this study was the frequent and structured contact during the
intervention, which enabled many participants to achieve meaningful weight loss.One
limitation was that only 11% of the participants in this study were men, which restricted our
analyses of sex-specific responses. In addition, no participants in this study were diabetic,
thus our findings are not generalizable to this large segment of the severely obese
population. However, our results indicate the important role of insulin resistance in carotid
intima-media thickening even in non-diabetic severely obese individuals. In addition, 40
participants in the parent randomized trial did not have carotid ultrasound scans at both time
points, mainly due to scheduling difficulties. We detected no significant baseline differences
between individuals with and without complete carotiddata in factors found to influence
CIMT or AD changes (results not shown).Moreover, results from sensitivity analyses
including individuals with baseline but no follow-up carotid data were very similar to those
reported. The small sample size of this study certainly limited our power to detect
differences by intervention arm or by subgroups of interest, particularly for the vascular
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changes, which showed considerable heterogeneity. Finally, no control group was used for
the dietary intervention, which prevented us from establishing with certainty the causal
effects of the dietaryintervention.
In conclusion, a 6-month intensive dietary intervention either with or without physical
activity can result in clinically meaningful improvements in cardiometabolic risk factors and
common carotid artery geometry in severely obese adults. Moreover, these data indicate that
weight-loss induced reductions in insulin resistance and abdominal fat are particularly
associated with improvements in vascular health, benefits that are most evident in the most
severely obese.
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Table 1
Participant Characteristics at Baseline
Total (n=90) Diet (n=45) Diet+PA (n=45) P
Age (years) 47.1 (6.4) 47.5 (6.2) 46.8 (6.5) 0.62
Male, n (%) 10 (11.1) 2 (4.4) 8 (17.8) 0.04
African American race, n (%) 29 (32.2) 16 (35.6) 13 (28.9) 0.50
Current smoker, n (%) 8 (8.9) 2 (4.4) 6 (13.3) 0.27
Blood pressure medication use, n (%) 35 (38.9) 15 (33.3) 20 (44.4) 0.28
Lipid lowering medication use, n (%) 13 (14.4) 7 (15.6) 6 (13.3) 0.76
Obesity severity, n (%)
  Class II (BMI 35-39.9 kg/m2) 25 (27.8) 12 (26.7) 13 (28.9) 0.81
  Class III (BMI ≥ 40 kg/m2) 65 (72.2) 33 (73.3) 32 (71.1)
BMI (kg/m2) 43.9 (5.7) 44.0 (6.6) 43.8(4.8) 0.87
Weight (kg) 120.2 (17.9) 118.6 (16.6) 121.9 (19.2) 0.38
Waist circumference (cm) 123.0 (12.6) 121.2 (12.6) 124.8 (12.6) 0.18
Body fat (kg) 61.0 (12.0) 60.4 (12.2) 61.6 (12.0) 0.64
Fat free mass (kg) 58.0 (8.9) 57.0 (7.1) 59.0 (10.4) 0.29
Abdominal visceral fat (cm2)a 200.3 (71.0) 186.9 (62.9) 213.7 (76.7) 0.08
Abdominal subcutaneous fat (cm2)a 740.4 (180.6) 739.3 (187.2) 741.5 (175.8) 0.96
Systolic blood pressure (mm Hg) 135.2 (12.6) 133.4 (16.6) 135.9 (11.0) 0.61
Diastolic blood pressure (mm Hg) 77.2 (8.1) 76.6 (8.5) 77.8 (7.9) 0.51
Glucose (mmol/L) 5.2 (0.6) 5.2 (0.6) 5.2 (0.6) 0.92
Insulin (pmol/L)b 109.7 (63.9) 104.2 (59.7) 115.3 (68.8) 0.42
Homeostatic model assessment of insulin resistance
(mmol/L × μU/mL)b
3.7 (2.3) 3.5 (2.1) 3.9 (2.6) 0.42
Leptin (μg/L)b 53.7 (22.4) 55.2 (21.6) 52.4 (23.3) 0.55
Adiponectin (μg/mL)c 3.9 (1.9) 4.3 (2.0) 3.6 (1.8) 0.14
Triglycerides (mmol/L) 1.2 (1.0, 1.7) 1.3 (1.0, 1.5) 1.2 (0.9, 1.8) 0.82
Total cholesterol (mmol/L) 4.9 (0.8) 5.0 (0.7) 4.9 (0.9) 0.80
High density lipoprotein cholesterol (mmol/L) 1.2 (0.3) 1.3 (0.3) 1.2 (0.3) 0.34
Low density lipoprotein cholesterol (mmol/L) 3.2 (0.7) 3.2 (0.7) 3.2 (0.8) 0.98
C-reactive protein (mg/L) 6.9 (3.4, 11.3) 5.5 (3.3, 11.8) 8.2 (4.4, 10.6) 0.34
Number of steps per dayd 7411.4 (2965.7) 7340.1 (2861.5) 7479.5 (3092.8) 0.83
Moderate activity (min/week)d 604.8 (440.6) 605.6 (485.5) 602.3 (398.6) 0.97
Vigorous activity (min/week)d 28.6 (11.3, 63.4) 22.8 (9.2, 48.3) 31.1 (17.6, 82.3) 0.05
Mean CIMT (mm) 0.77 (0.10) 0.77 (0.11) 0.77 (0.10) 0.91
Mean AD (mm) 7.14 (0.61) 7.12 (0.60) 7.16 (0.63) .76
Values are mean (SD), median (25th, 75th percentiles), or n (%); P-values are from independent samples t-test or Mann-Whitney U test for
continuous variables; p-value by chi-square test or Fisher’s Exact test for categorical variables
a
n= 44 Diet, 44 Diet+PA
b
n=43 Diet;
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c
n= 36 Diet, 41 Diet+PA
d
n=43 Diet, 45 Diet+PA; AD=common carotid artery inter-adventitial diameter; BMI=body mass index; CIMT=common carotid artery intima-
media thickness; PA=physical activity
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Table 3
Pearson Correlations between common carotid artery structural changes and demographic variables or changes
in cardiometabolic factors
Variable Change in AD Change in CIMT
Baseline demographic variables
   Age 0.23* −0.13
   Male sex −0.24* 0.02
   African American race 0.002 0.09
Six month change variables
   Inter-adventitial diameter ---- 0.10
   Weight 0.32* 0.25*
   Body mass index 0.31* 0.23*
   Waist circumference 0.23* 0.24*
   Systolic blood pressure −0.06 −0.19
   Diastolic blood pressure 0.02 −0.17
   Glucose 0.06 0.03
   High density lipoprotein cholesterol 0.09 −0.15
   Low density lipoprotein cholesterol 0.08 −0.04
   Triglycerides 0.18 0.11
   Number of steps/day −0.13 −0.02
   Moderate Activity min/week −0.09 0.05
   Vigorous Activity min/week −0.09 0.006
   Abdominal Visceral Fat 0.24* 0.14
   Abdominal Subcutaneous Fat 0.35* 0.10
   Body fat mass 0.39* 0.13
   Fat free mass 0.15 0.31*
   Adiponectin 0.13 −0.02
   C-reactive protein 0.07 0.11
   Leptin 0.07 0.22*
   Insulin 0.19 0.30*
All variables shown were evaluated as changes from baseline except age, sex, and race.
*
P<0.05 from Pearson correlation analysis; AD=common carotid artery inter-adventitial diameter; CIMT=common carotid artery intima-media
thickness
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Table 4
Multivariable Linear Regression Models for 6 Month Change in Common Carotid Artery Intima-Media
Thickness
Model Variable Parameterestimate s.e P
Model 1 (R2=0.06)a
Diet Arm 0.0024 0.012 0.84
Change in BMI (kg/m2)b 0.0058 0.003 0.03
Model 2 (R2=0.11)c
Diet Arm 0.0046 0.012 0.70
Change in BMI (kg/m2)b 0.0032 0.003 0.45
Change in Insulin (μU/mL)b 0.0017 0.0008 0.03




BMI and insulin were evaluated as changes from baseline.
c
Model 2 n=87. BMI=body mass index.
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Table 5






Diet Arm 0.01 0.04 0.80
Age (years) 0.006 0.003 0.07
Male sex −0.14 0.06 0.04
Change in BMI (kg/m2)b 0.03 0.009 0.002
Model 2 (R2=0.25)c
Diet Arm 0.003 0.04 0.95
Male sex −0.16 0.06 0.01
Age (years) 0.005 0.003 0.15
Change in BMI (kg/m2)b 0.02 0.01 0.03
Change in Abdominal subcutaneous
fat (cm2)b 0.0005 0.0002 0.04




BMI and abdominal subcutaneous fat were evaluated as changes from baseline;
c
Model 2 n=88. BMI=body mass index.
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